CX3CL1, also named fractalkine or neurotactin, is the only known member of the CX3C
chemokine family that can chemoattract several immune cells. CX3CL1 exists in both …

Non-obstructive coronary artery disease (NO-CAD) constitutes a heterogeneous group of
conditions collectively characterized by less than 50% narrowing in at least one major …

The objective of our study was to evaluate the concentrations of pro-inflammatory
biomarkers in patients with acute myocardial infarction with non-obstructive coronary …

Background The fibrinogen-to-albumin ratio (FAR) has been identified as a new
inflammatory marker for predicting the risk of cardiovascular diseases. Nevertheless, its …

Background Diabetes mellitus is a major cardiovascular risk factor for the development of
coronary artery disease, but knowledge about the impact of diabetes mellitus on the …

Myocardial infarction with non-obstructive coronary arteries (MINOCA) is a clinical entity
characterized by the absence of significant coronary artery obstruction in epicardial arteries …

Background The Systemic Inflammation Response Index (SIRI) and N-terminal Pro–B-type
natriuretic peptide (NT-proBNP) have been proposed as reliable predictors of poor …

CX3CL1, also named fractalkine or neurotactin, the only known member of the CX3C
chemokine family that can chemoattract several immune cells. CX3CL1 exists in both …

Myocardial Infarction with Non-Obstructive Coronary Arteries (MINOCA) is a clinical entity
characterized by the absence of significant coronary artery obstruction in epicardial arteries …

Cardiovascular diseases, notably myocardial infarction (MI), contribute significantly to global
mortality. While traditional MIs are often associated with notable coronary artery blockages …